Meet the Founder
Vaidya Balendu Prakash is an acclaimed Ayurvedic Physician, who also served as Physician to the President of India, Shri K. R. Narayanan. Born in the family of a Rasa Vaidya, Prakash mainly practices Rasa Shastra, combining the traditional knowledge of Ayurveda with modern science. During his nearly four decades of clinical experience, Prakash has conceptualized and developed research-based products, all based on classical references mentioned in Ayurvedic texts, including a few developed by his father Vaidya Chandra Prakash, who was also a Rasa vaidya. These products have been based on clinical evidence created by Prakash following good clinical practice. Some of his innovative treatment protocols for diseases like Recurrent Acute/ Chronic Pancreatitis, Anaemia, Migraine, Multiple Sclerosis, Allergic Rhinitis, Acute Promyelocytic Leukaemia (APML), and Childhood Asthma have benefitted many patients and their families.
Vaidya Balendu Prakash has travelled extensively around the globe in relation to treatment of patients and to attend conferences, seminars and symposiums with more than 300 foreign trips so far. He was conferred the Padamshri in 1999 by the Government of India for his contributions in treating APML, which later received national and international patent, and fetched him life membership of the Indian Cooperative Oncology Network (ICON). He is also the member of the International Headache Society and American Pancreatic Society. He has authored about 32 research papers in both national and international journals of repute. He has delivered more than 250 lectures in seminars and webinars across the country.
He has also presented his work at various international conferences, including 3rd International Conference on Hepatobiliary and Pancreatic Disorders, Philadelphia, USA, 4th World Congress on Digestive and Metabolic Diseas-es, San Francisco, USA, and 50th Joint Annual Meet of American Pancreatic Association and Japan Pancreas Society, Hawaii, USA.
Rasa Shastra is a specialized branch of Ayurveda which evolved from 1st to 5th century in India. The branch deals with therapeutics of substances of plant, animal and mineral origin, which are moderate to severely toxic in raw form. There are various methodologies to transform them into non-toxic therapeutic form. However, use of mercury and heavy metals in ayurvedic medicines has always remained a controversial issue. There is dearth of adverse reports regarding the toxic effect of metals and minerals in ayurvedic drugs. While ayurvedic community goes into playing defensive mode by claiming that appropriate processing of metals and mercury transform those into non-toxic form, the non-ayurvedic community never recognises ayurvedic formulation as medicines. In fact, these formulations have gradually been categorised as food supplements or essentials for wellness. On the other hand, there are many incidences or stories regarding the miraculous lifesaving effects of Rasa-aushadhies.
Ayurveda was largely practiced under Guru-Shishya Parampara at the Gurukuls/ Ashramas/ Mathas in ancient India. Meerut based Late Vaidya Chandra Prakash Ji learnt the applied aspects of Rasa Shastra from his Guru Maharaj Ji, who was a master of Yoga and Rasa Shastra. He had also obtained basic degree of "Bhishak" from SD College, Lahore (now in Pakistan). He started his clinical practise by using his own prepared Ayurvedic medicines with more emphasis on Rasa-aushadhies. Gradually he earned reputation in treating certain forms of cancer, acute and chronic/ relapsing communicable diseases. In mid seventies, he started preparing a formulation using processed copper, mercury and sulphur. Firsthe amalgamated these in the solution of Lufta echinate and Clitoria ternatea in lemon juice and then subjected the mixture to the concept of repeated Gandhakjarana using Nalika Damru Yantra. The aforesaid processing when done repeatedly lead to Gandhakjeerna parad (assimilated form of sulphur with mercury). The said formulation named as Amar was incidentally administered to a terminally ill patient of pancreatic disorder. That particular batch of Amar also helped in bringing complete and sustainable relief to few other patients suffering with advanced stage of solid tumors.
Unfortunately, Late Vaidya could not succeed in reproducing the identical batches due to lack of information and resources for developing Standards Operating Procedures (SOPs).
This formulation could be revived in early eighties when his fifth son (Vaidya Balendu Prakash) who was then a second-year student of BAMS (Ayurvedacharya) assisted him in the preparation of medicines. A fact-finding committee headed by Dr. R.C.D. Nautiyal, the then deputy Director of Central Council for Research and Ayurveda and Siddha, Ministry of Health and Family Welfare, Government of India acknowledged the efficacy of successful treatment of certain cancers and recommended for further researches for its scientific development in 1983.
The pioneer work of Late Vaidya was carried forward after his untimely death in 1984. A retrospective analysis of decades long clinical practise revealed that Amar has been able to bring miraculous recoveries to well diagnosed cases of recurring acute and chronic pancreatitis with sustainable results. Later, the clinical data of each and every enrolled patient was documented following Comte's model of research. A total number of 48 patient were enrolled between January 1997 and September 2014 and these observations were brought to the public domain in the form of a day seminar where beneficiaries of ayurvedic treatment, policy makers, scientists and researchers of Ayurveda and modern medicine actively participated. The event was able to create public awareness about ayurvedic treatment of pancreatitis. The findings of ayurvedic practise were well documented following good clinical practise for observational research. Three consequent booklets have been released carrying clinical data of hundred, two hundred fifty and five hundred fifty-five enrolled patients of different variants of Pancreatitis. DG, UCOST, Government of Uttarakhand, Secretary, Science & Technology, Government of Uttarakhand and Former Secretary, Medical Research and Former DG, ICMR, Ministry of Health and Family Welfare, Government of India have written foreword of these booklets adding more value to the generated data. Subsequently, these findings were also published and presented at numerous national and international journals and forums including 50th joint annual meeting of American Pancreatic Association and Japan Pancreas Society; October - November 2019, Hawaii, USA.
The great art of Rasa Shastra was introduced into Ayurveda after decades of committed efforts of Indian sages. Amar had been developed by Late Vaidya Chandra Prakash Ji using ancient wisdom of Rasa Shastra and Amar could also bring miraculous recoveries in pancreatitis patients. There was dire need to understand the intrinsic phenomena of science behind its efficacy. Therefore, Amar has systematically been developed to ascertain reproducibility, safety and efficacy.
Hence, Amar has undergone process standardization and characterization using non destructive methods, XRD, EDAX and SEM under the guidance of Professor S. Vasudevan, Department of Inorganic and Physical Chemistry, Indian Institute of Sciences, Bengaluru. The findings have revealed that there are no traces of any free metal in the finished product and there is a visible transformation of metals into intrigue mineral form. The finding has been published and a patent has also been filed with competent authorities.Amar has also undergone safety evaluation by conducting acute, sub- acute and chronic toxicity studies in rats by an internationally accredited and DSIR approved CRO. The result of these studies depicts "No Observed Adverse Effect Level (NOAEL)" in much higher doses than the administered one.
Two consecutive experimental studies to study pancreatitis protective properties of Amar in rodents by using L-Arginine induced chronic pancreatitis have established that Amar has significantly strong pancreatitis protective properties. In another observation, Amar has also demonstrated CA 19-9 lowering effect in the diagnosed cases of RACP. CA19-9 is a biomarker which stands for cancer antigen 19-9 and is used to evaluate the progression/ regression of the disease. Ayurvedic treatment protocol has been found effective in normalizing the CA 19-9 levels of 38 to 4000 units in majority of the cases. The aforesaid observations might be of significant importance due to the fact that pancreatitis is a well-conceived precursor for pancreatic cancer and the patients having elevated CA 19-9 levels more than 300 have been considered indicative of cancer of pancreas. The results of both the studies have also been published to put the information in order.
Pancreatitis is a miserable disease of pancreas with rising number of cases worldwide. Ayurvedic treatment might open up a new path towards the management of the disease. This booklet is a medium to disseminate information on Pancreatitis and developments of Ayurvedic treatment approach.
Vaidya Balendu Prakash
Ayurvedic Consultant & Founder Director, Padaav - Speciality Ayurvedic Treatment Centre